Is Post-Transplant Cyclophosphamide the New Methotrexate?
J Clin Med. 2021 Aug 12;10(16):3548. doi: 10.3390/jcm10163548.ABSTRACTIntroducing…
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
Bone Marrow Transplant. 2021 Dec;56(12):2911-2921. doi: 10.1038/s41409-021-01288-9.…
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?
Blood. 2021 Nov 11;138(19):1901-1905. doi: 10.1182/blood.2021012319.NO…
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
Nat Commun. 2021 Jul 14;12(1):4319. doi: 10.1038/s41467-021-24618-3.ABSTRACTDespite…
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases
Mol Cancer. 2021 Jun 6;20(1):86. doi: 10.1186/s12943-021-01370-2.ABSTRACTBACKGROUND:…
SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment
Cancers (Basel). 2021 May 17;13(10):2412. doi: 10.3390/cancers13102412.ABSTRACTThe…
Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies
Dis Model Mech. 2021 Jul 1;14(7):dmm048223. doi: 10.1242/dmm.048223.…
Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies
Dis Model Mech. 2021 Jul 1;14(7):dmm048223. doi: 10.1242/dmm.048223.…
Dose intensity and treatment duration of bortezomib in transplant-ineligible newly diagnosed multiple myeloma
Eur J Haematol. 2021 Aug;107(2):246-254. doi: 10.1111/ejh.13643.…
Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma
Cancer Med. 2021 May;10(10):3214-3223. doi: 10.1002/cam4.3881.…
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
Eur J Cancer. 2021 Jun;150:190-202. doi: 10.1016/j.ejca.2021.03.035.…
Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis
Blood Cancer J. 2021 Apr 29;11(4):82. doi: 10.1038/s41408-021-00472-w.NO…
